731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis

by Jonathan Kish, Dhruv Chopra, Djibril Liassou, Solomon Lubinga, John Hartman, Bruce Feinberg
Published 2020-11-01